Page last updated: 2024-10-22

amiodarone and Developmental Disabilities

amiodarone has been researched along with Developmental Disabilities in 1 studies

Amiodarone: An antianginal and class III antiarrhythmic drug. It increases the duration of ventricular and atrial muscle action by inhibiting POTASSIUM CHANNELS and VOLTAGE-GATED SODIUM CHANNELS. There is a resulting decrease in heart rate and in vascular resistance.
amiodarone : A member of the class of 1-benzofurans that is 1-benzofuran substituted by a butyl group at position 2 and a 4-[2-(diethylamino)ethoxy]-3,5-diiodobenzoyl group at position 3. It is a cardiovascular drug used for the treatment of cardiac dysrhythmias.

Developmental Disabilities: Disorders in which there is a delay in development based on that expected for a given age level or stage of development. These impairments or disabilities originate before age 18, may be expected to continue indefinitely, and constitute a substantial impairment. Biological and nonbiological factors are involved in these disorders. (From American Psychiatric Glossary, 6th ed)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Creo, A1
Anderson, H1
Cannon, B1
Lteif, A1
Kumar, S1
Tebben, P1
Iqbal, AM1
Ramakrishna, A1
Pittock, S1

Other Studies

1 other study available for amiodarone and Developmental Disabilities

ArticleYear
Patterns of amiodarone-induced thyroid dysfunction in infants and children.
    Heart rhythm, 2019, Volume: 16, Issue:9

    Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Child; Developmental Disabilities; Early D

2019